Rydex Biotechnology Fund Class Investor (RYOIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
59.09
-1.22 (-2.02%)
May 12, 2025, 8:09 AM EDT
-17.21% (1Y)
| Fund Assets | 85.78M |
| Expense Ratio | 1.40% |
| Min. Investment | $2,500 |
| Turnover | n/a |
| Dividend (ttm) | 9.42 |
| Dividend Yield | 15.95% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 60.31 |
| YTD Return | -8.37% |
| 1-Year Return | -5.63% |
| 5-Year Return | -2.41% |
| 52-Week Low | 55.59 |
| 52-Week High | 82.61 |
| Beta (5Y) | 0.76 |
| Holdings | 80 |
| Inception Date | Mar 31, 1998 |
About RYOIX
The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Fund Family Rydex Investor Class
Category Health
Stock Exchange NASDAQ
Ticker Symbol RYOIX
Share Class Investor Class
Index S&P 500 TR
Performance
RYOIX had a total return of -5.63% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.24%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.63% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
41.01% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 9.13% |
| Amgen Inc. | AMGN | 5.92% |
| Gilead Sciences, Inc. | GILD | 5.74% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.43% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.66% |
| Corteva, Inc. | CTVA | 2.92% |
| AstraZeneca PLC | AZN | 2.49% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.41% |
| First American Government Obligations Fund | FGXXX | 2.24% |
| Royalty Pharma plc | RPRX | 2.07% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 12, 2024 | $9.42277 | Dec 12, 2024 |
| Dec 20, 2022 | $0.89943 | Dec 20, 2022 |
| Dec 8, 2021 | $15.77303 | Dec 8, 2021 |
| Dec 9, 2020 | $6.95038 | Dec 9, 2020 |
| Dec 10, 2019 | $3.60206 | Dec 10, 2019 |
| Dec 11, 2018 | $9.88842 | Dec 11, 2018 |